“Adenosine Monophosphate-Activated Protein Kinase (AMPK) As a New Target for Antidiabetic Drugs: A Review on Metabolic, Pharmacological and Chemical Considerations ”. 2023. The Review of Diabetic Studies 6 (1). https://www.diabeticstudies.org/index.php/RDS/article/view/252.